Found: 6
Select item for more details and to access through your institution.
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 509, p. 1, doi. 10.1126/scitranslmed.aaw8412
- By:
- Publication type:
- Article
Micronuclei-based model system reveals functional consequences of chromothripsis in human cells.
- Published in:
- eLife, 2019, p. 1, doi. 10.7554/eLife.50292
- By:
- Publication type:
- Article
CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials.
- Published in:
- eLife, 2017, p. 1, doi. 10.7554/eLife.24179
- By:
- Publication type:
- Article
Combustible and Electronic Cigarette Exposures Increase ACE2 Activity and SARS-CoV-2 Spike Binding.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2022, v. 205, n. 1, p. 129, doi. 10.1164/rccm.202106-1377LE
- By:
- Publication type:
- Article
Evolving copy number gains promote tumor expansion and bolster mutational diversification.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46414-5
- By:
- Publication type:
- Article
Gender disparities among independent fellows in biomedical research.
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 10, p. 1018, doi. 10.1038/nbt.4274
- By:
- Publication type:
- Article